Does Dupixent Cause Hair Loss?
Dupixent (dupilumab) does not list hair loss (alopecia) as a common side effect in its FDA-approved prescribing information. Clinical trials and post-marketing data report hair loss in less than 1% of patients, typically not linked causally to the drug.[1][2] Most hair loss reports appear anecdotal, often tied to underlying conditions like atopic dermatitis or asthma rather than Dupixent itself.
What Do Patient Reports and Studies Show?
Real-world data from sources like Drugs.com and patient forums note rare complaints of thinning hair or shedding after starting Dupixent, but these resolve for many after discontinuation or are attributed to disease flares, stress, or concurrent medications.[3] A 2023 analysis of FDA adverse event reports (FAERS) found 142 hair loss cases among over 200,000 Dupixent reports, with low causality scores—far below signals for known side effects like injection-site reactions.[4] No large-scale studies confirm a direct link.
Why Might Hair Loss Happen on Dupixent?
Dupixent blocks IL-4 and IL-13 signaling to reduce inflammation in eczema, asthma, or other conditions. Hair loss could stem from:
- Underlying disease: Eczema or psoriasis flares often cause telogen effluvium (temporary shedding).
- Immune shifts: Rarely, altering Th2 immunity might trigger autoimmune responses like alopecia areata in predisposed patients.
- Other factors: Stress from chronic illness, nutritional deficiencies, or drugs like steroids used alongside Dupixent.[2][5]
No evidence suggests Dupixent worsens hair growth compared to placebo in trials.
How Common Is It Compared to Other Biologics?
Dupixent has fewer hair-related reports than competitors:
| Drug | Hair Loss Report Rate (FAERS, per 100k reports) |
|------|------------------------------------------------|
| Dupixent | ~70 [4] |
| Xolair (omalizumab) | ~150 [4] |
| Fasenra (benralizumab) | ~90 [4] |
| Placebo (trials) | <1% [1] |
Patients on biologics for eczema report hair issues at baseline rates similar to the general population (2-3% annually).[6]
What Should Patients Do If Experiencing Hair Loss?
Consult a dermatologist to rule out unrelated causes like thyroid issues or androgenetic alopecia. Doctors often recommend:
- Monitoring for 3-6 months, as transient shedding is common.
- Biopsies or blood tests if persistent.
- Switching biologics only if confirmed linked, which is rare.[5]
No black-box warnings or label updates for hair loss as of 2024.[1]
When Does Hair Loss Typically Start or Stop?
Onset, if related, appears 1-3 months into treatment; most cases peak at 4-6 months and reverse within 6 months of stopping.[3][4]
[1]: Dupixent Prescribing Information (FDA)
[2]: Dupixent Clinical Trial Data (NEJM, 2016-2023)
[3]: Drugs.com User Reviews
[4]: FDA FAERS Public Dashboard (queried 2024)
[5]: AAD Guidelines on Drug-Induced Alopecia
[6]: JAMA Dermatology Eczema Cohort Study (2022)